On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
On Aug. 20, 2020, the La Jolla Institute for Immunology (LJI) announced that Erica Ollmann Saphire, Ph.D. had…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
On Apr. 10, 2020, the U.S. Department of Veterans Affairs (VA) established the VA History Office (VAHO) to…
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
On Mar. 31, 2020, VIVUS announced the accelerated launch of the telemedicine and remote monitoring modules of the…
On Mar. 30, 2020, the Military Sealift Command hospital ship USNS Comfort to join COVID-19 fight in New…
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed…
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…